Cardiac surgery and cold-reactive proteins

https://doi.org/10.1016/0003-4975(95)00501-BGet rights and content

Cold agglutinins are commonly found in sera of healthy persons. They rarely become clinically apparent due to their activity at low temperatures. In these patients, cardiovascular operations requiring hypothermia can result in complications such as hemolysis, renal failure, and myocardial damage and can cause unexpected morbidity and mortality. The literature on cold-reactive proteins is reviewed, and methods of diagnosis and management related to cardiac surgery are suggested. Ideally all patients should be routinely tested preoperatively for the antibodies, and appropriate changes in cardiopulmonary bypass and myocardial management plans should be made in positive patients. Preoperative plasmapheresis may be a useful adjunct, especially in patients requiring operation under profound hypothermia and circulatory arrest. Currently, warm heart surgery appears to be the most expedient method. Unexpected detection of agglutination during operation or hemolysis after operation requires a specific treatment plan.

References (47)

  • AokiA et al.

    Cardiac operation without hypothermia for the patient with cold agglutinin

    Chest

    (1993)
  • KoppulaAS et al.

    Management of cold agglutinemia using normothermic intermittent fibrillatory arrest

    Ann Thorac Surg

    (1994)
  • CrispD et al.

    B-cell neoplasms with homogenous cold-reacting antibodies (cold agglutinins)

    Am J Med

    (1982)
  • RosseWF et al.

    The variability of hemolysis in the cold agglutinin syndrome

    Blood

    (1980)
  • WertlakePT et al.

    Cold antibody and persistent intravascular hemolysis after surgery under hypothermia

    Transfusion

    (1969)
  • KleinHG et al.

    Surgical hypothermia in a patient with a cold agglutinin: management by plasma exchange

    Transfusion

    (1980)
  • WilliamsAC

    Cold agglutinins: cause for concern?

    Anaesthesia

    (1980)
  • LandymoreR et al.

    Management of patients with cold agglutinins who require open heart surgery

    Can J Surg

    (1983)
  • BlumbergN et al.

    Successful cardiac bypass surgery in the presence of a potent cold agglutinin without plasma exchange

    Transfusion

    (1983)
  • LeachAB et al.

    Cold agglutinins and deep hypothermia

    Anaesthesia

    (1983)
  • DiazJH et al.

    Cardiac surgery in patients with cold autoimmune diseases

    Anesth Analg

    (1984)
  • ParkJV et al.

    Cardiopulmonary bypass and myocardial protection: management problems in cardiac surgical patients with cold autoimmune disease

    Anesth Analg

    (1988)
  • LeeMC et al.

    Use of a total wash-out method in an open heart operation

    Ann Thorac Surg

    (1989)
  • Cited by (72)

    • Perioperative management of cold agglutinin autoimmune hemolytic anemia in an older adult undergoing radical cystectomy for bladder cancer

      2019, Urology Case Reports
      Citation Excerpt :

      Few reports exist regarding the optimal management of CAD in the perioperative setting, especially for major urologic procedures. Description of the surgical ramifications of CAD is more robust in the cardiothoracic literature due to the unique challenges of managing CAD in the setting of cardiopulmonary bypass.3,4 Hemolysis occurs when both titer levels of cold agglutinin are sufficiently elevated and temperature is sufficiently low.

    View all citing articles on Scopus
    View full text